Next Generation CAR-TCR Summit
The cell therapy field is showing no signs of slowing down, with huge investment and excitement around next generation products and their clinical validation in solid tumour indications.
Formerly CAR-TCR Europe, the new and improved Next Generation CAR-TCR Therapies Summit is now the only industry-dedicated forum focused on the 2.0, next generation innovations in cell therapies.
This year, we’ll be specifically focusing on next generation cell therapies and discussing:
- Novel in vivo delivery
- How we can bring to market safer, more effective, and affordable cell therapies, going beyond T cells and oncology indications
- How to innovate with gene, base and prime editing to control and target cell therapies better
- How we can create the therapies of tomorrow
Join over 200 adoptive cell therapy experts from the most innovative companies accelerating the 3rd, 4th and 5th generation advanced therapies to the clinic across 3 days of carefully curated sessions.
Be part of the conversation as we explore novel in-vivo delivery and leverage innovative developments from early discovery through to manufacturing to bring to market the next generation of cell therapies.